BICARA THERAPEUTICS INC

BCAX · NASDAQ

Updated at 2026-10-15 11:19:34

$17.34+0.00%
Today's High
$17.68
Today’s Low
$17.11
BICARA THERAPEUTICS INC (BCAX) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$17.23
Previous Close
$17.34
Volume
1.42M
Market Cap
$1.14B
P/E Ratio
--
EPS
$-3.08

Previous Day Range

$17.11$17.68

52-Week Range

$13.70$30.99

Company Overview

Sector
HEALTHCARE
Industry
Biotechnology
Sub-industry
BIOTECHNOLOGY
Headquarters
116 HUNTINGTON AVENUE, BOSTON, MA, UNITED STATES, 02116
Country
US
Listing Date
2024-09-13
Fiscal Year End
December
Shares Outstanding
65.7M
CIK
0002023658

Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, develops bifunctional therapies for solid tumors. The company is headquartered in Boston, Massachusetts.

Financial Metrics

Revenue

2026-06-30

$0

2026-03-31

$0

2025-12-31

$0

2025-09-30

$0

Operating Expenses

2026-06-30

$59.95M

2026-03-31

$60.24M

2025-12-31

$41.12M

2025-09-30

$40.67M

Net Income

2026-06-30

-$55.43M

2026-03-31

-$56.21M

2025-12-31

-$37.38M

2025-09-30

-$36.33M

Net Profit Margin

2026-06-30

--

2026-03-31

--

2025-12-31

--

2025-09-30

--

Earnings Per Share

2026-06-30

$-0.82

2026-03-31

$-0.93

2025-12-31

$-0.68

2025-09-30

$-0.67

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-06-30

-$55.33M

2026-03-31

-$56.11M

2025-12-31

-$37.29M

2025-09-30

-$36.26M

Effective Tax Rate

2026-06-30

-0.11%

2026-03-31

0.09%

2025-12-31

-0.14%

2025-09-30

-0.11%

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.